Sign in

CIK 0001087294 · Non-accelerated filer<br>Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
operating
EIN
621765329
Phone
615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
  1. 4 Grant or award Chairman and CEO acquired 35,000 shares (grant or award)
  2. 4 Grant or award Director acquired 1,000 shares (grant or award)
  3. 4 Grant or award Director acquired 1,000 shares (grant or award)
  4. 4 Grant or award Director acquired 1,000 shares (grant or award)
  5. 4 Grant or award Director acquired 500 shares (grant or award)
  6. 4 Grant or award Chief Financial Officer acquired 3,000 shares (grant or award)
  7. 4 Grant or award Sr VP/Chief Commercial Officer acquired 3,000 shares (grant or award)
  8. 4 Grant or award Director acquired 1,000 shares (grant or award)
  9. 4 Option exercise Director acquired 7,600 shares (option exercise)
  10. 4 Grant or award Chief Financial Officer acquired 30,000 shares (grant or award)
  11. 4 Open-market sale Director sold 65,000 shares at $5.80 ($377,000)
  12. 4 Open-market sale Director sold 20,000 shares at $5.73 ($114,600)
  13. 4 Open-market sale Sr. VP & Corp. Secretary sold 2,618 shares at $5.73 ($15,001)
  14. 4 Open-market sale Director sold 3,786 shares at $5.73 ($21,694)
  15. 4 Open-market sale Director sold 1,310 shares at $5.73 ($7,506)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale Sr. Vice President, Operations sold 1,700 shares at $5.91 ($10,047)
  18. 4 Returned to the company Vice President and CFO returned 3,000 shares (to the company)
  19. 4 Open-market sale Director sold 20,000 shares at $5.28 ($105,600)
  20. 4 Grant or award Sr. Vice President, Operations acquired 5,000 shares (grant or award)

Page 23 of 26 · 512 filings